Angela Subbiani
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.
Journal: Cancer research
Published: April 13, 2025
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer.
Journal: Breast cancer research : BCR
Published: February 04, 2025
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease.
Journal: Cell death & disease
Published: April 12, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer.
Journal: Science translational medicine
Published: February 28, 2024
Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma.
Journal: Cancers
Published: August 11, 2023
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer.
Journal: EMBO molecular medicine
Published: June 29, 2023
β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma.
Journal: Cancer gene therapy
Published: August 09, 2022
β2-and β3-Adrenergic Receptors Contribute to Cancer-Evoked Pain in a Mouse Model of Osteosarcoma via Modulation of Neural Macrophages.
Journal: Frontiers in pharmacology
Published: April 20, 2021
Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression.
Journal: Oxidative medicine and cellular longevity
Published: March 27, 2020
β3-Adrenoceptors as Putative Regulator of Immune Tolerance in Cancer and Pregnancy.
Journal: Frontiers in immunology
Published: March 15, 2020
β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment.
Journal: International journal of molecular sciences
Published: January 29, 2020
Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells.
Journal: Oxidative medicine and cellular longevity
Published: September 27, 2019
Last Updated: 09/26/2026